We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
 

Latest News

DNA Methylation Analysis of Bone Marrow Cells at Diagnosis of Acute Lymphoblastic Leukemia and at Remission
News   Apr 16, 2012

The aim of this study was to identify genes that display aberrant DNA methylation independently of cytogenetic ALL subtype for further mechanistic studies of ALL.

READ MORE

Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Nanomolar Potency
News   Apr 13, 2012

This article looks at prediction of cancer drug efficacy in its ultimate user, the human patient and reviews current knowledge followed by illustrative examples that, in the absence of definitive data, provide an empirical perspective.

READ MORE

A*STAR and GE Global Research Sign Memorandum of Understanding
News   Apr 13, 2012

Agreement to develop integrated advanced medical imaging technologies for improved clinical diagnosis.

READ MORE

Enzo Biochem Launches Test for Measuring Risk of Colorectal Cancer
News   Apr 12, 2012

Company developing pipeline of new platforms and assays for molecular diagnostic use.

READ MORE

Oxygen Levels Do Not Determine Radiation Survival of Breast Cancer Stem Cells
News   Apr 12, 2012

Today, oxygen is recognized to be one of the most powerful radiation sensitizers. This study outlines research into how breast cancer stem cells are protected from radiation through expression of free radical scavengers, with little increase provided by hypoxia.

READ MORE

immatics Appoints Dr Rainer Kramer as CBO
News   Apr 12, 2012

Dr. Kramer will lead immatics’ business development unit.

READ MORE

Rigged to Explode?
News   Apr 11, 2012

Inherited mutation links exploding chromosomes to cancer.

READ MORE

Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat
News   Apr 10, 2012

Drug studied in combination with Lapatinib in HER2-positive metastatic breast cancer.

READ MORE

Researchers Develop a New Cell and Animal Model of Inflammatory Breast Cancer
News   Apr 10, 2012

The new model, developed by researchers at the Fox Chase Cancer Center, may provide scientists with a better understanding of the disease and help with developing effective intervention.

READ MORE

AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer
News   Apr 06, 2012

Agreement demonstrates AMRI’s commitment to value creation from its proprietary portfolio of compounds and programs.

READ MORE

 
Advertisement